| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/164.3.533 |
| P698 | PubMed publication ID | 1869840 |
| P2093 | author name string | S B Formal | |
| R E Olsen | |||
| P J Snoy | |||
| E V Oaks | |||
| J P Cogan | |||
| M Wingfield-Eggleston | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella flexneri | Q1644417 |
| Shigella sonnei | Q6382438 | ||
| P304 | page(s) | 533-537 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | |
| P478 | volume | 164 |
| Q57929967 | A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge |
| Q33676706 | A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). |
| Q34992202 | A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: a study protocol |
| Q33678906 | A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1 |
| Q64948328 | Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. |
| Q92822336 | An Oral Inoculation Infant Rabbit Model for Shigella Infection |
| Q40126474 | An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype. |
| Q35411990 | Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. |
| Q39810262 | Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q39519924 | Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection |
| Q37335984 | Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q35771562 | Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid |
| Q22065494 | Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T |
| Q91801450 | Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays |
| Q34545910 | Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine |
| Q38853686 | Detergent Isolation Stabilizes and Activates the Shigella Type III Secretion System Translocator Protein IpaC. |
| Q46938617 | Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q37713347 | Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies |
| Q55333715 | Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay. |
| Q34765669 | Differential response of the cynomolgus macaque gut microbiota to Shigella infection |
| Q60584774 | Enterobacteria and host resistance to infection |
| Q42262595 | Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model |
| Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
| Q50104933 | Histopathological study of rabbit intestinal mucosa infected with a hybrid strain of Shigella dysenteriae 1 carrying LPS biosynthesis genes of Salmonella enterica serovar typhimurium |
| Q33753646 | Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD) |
| Q99616552 | Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G |
| Q50176712 | Improving chances for successful clinical outcomes with better preclinical models |
| Q35480510 | Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier |
| Q36890938 | Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics |
| Q39517102 | Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine |
| Q35772614 | Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. |
| Q37163698 | Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production. |
| Q36365336 | Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis |
| Q36958047 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B |
| Q87281013 | Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes |
| Q51058305 | Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. |
| Q34120926 | Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q35443019 | Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a. |
| Q92968346 | Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development |
| Q38294092 | Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta) |
| Q59809065 | Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial |
| Q84554549 | Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers |
| Q34008338 | Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults |
| Q91881906 | Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis |
| Q34202171 | Shigella isolates from the global enteric multicenter study inform vaccine development |
| Q43432983 | Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. |
| Q92968788 | Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses |
| Q56383780 | Shigellosis |
| Q35227831 | Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a |
| Q34518265 | Status of vaccine research and development for Shigella |
| Q34000330 | Strategy for cross-protection among Shigella flexneri serotypes |
| Q33607442 | Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoid |
| Q40300987 | The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence. |
| Q39511268 | Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a |
| Q34071749 | Up-regulation of MUC2 and IL-1β expression in human colonic epithelial cells by Shigella and its interaction with mucins |
| Q33557800 | Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants |
Search more.